Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F13NQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,275
Award facts
- Contract value 100% obligated
- $11,274.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,274.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Gemtesa 75 mg tablets (90-count units). The contract is not set-aside and represents a child order under AmerisourceBergen's parent company, Cencora, Inc. Performance will be completed by January 9, 2026, at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under Cencora's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen, as a major pharmaceutical distributor, regularly fulfills federal procurement requirements for medications across multiple therapeutic domains. Gemtesa (mirabegron) is a beta-3 adrenergic agonist used to treat overactive bladder, reflecting the company's role in supplying both specialty and standard pharmaceutical products to military treatment facilities and veterans' healthcare systems. The competitively awarded delivery order demonstrates the contractor's established capability to meet federal medical supply requirements efficiently and within firm fixed pricing parameters typical of DLA pharmaceutical procurement operations.
Quick answers
Who was awarded contract SPE2DR26F13NQ?
SPE2DR26F13NQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26F13NQ worth?
The government has obligated $11,275 on SPE2DR26F13NQ.
Is contract SPE2DR26F13NQ an order under another contract?
Yes. SPE2DR26F13NQ is a delivery order under SPE2DR25D1110, an indefinite delivery contract.
Was contract SPE2DR26F13NQ competed?
The extent of competition for SPE2DR26F13NQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award